| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 |
| filingDate |
1997-08-04^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93874dd858a3fc7ba8ac42e902d14ba7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_049808631efc7ef0e5851528f9885f06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5bc52739bb5ba9f97a0d5a7ea14cd98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a3190e54d6e76d73d3033ef485b757 |
| publicationDate |
1998-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5849914-A |
| titleOfInvention |
Compounds formed by an asymmetric conjugate addition reaction |
| abstract |
This invention relates to a key intermediate in the synthesis of an endothelin antagonist and the synthesis of this key intermediate using an asymmetric conjugate addition reaction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7425557-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7037918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7045519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6489344-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6417185-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6046327-A |
| priorityDate |
1996-08-09^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |